Axa’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-70,277
| Closed | -$860K | – | 158 |
|
|
2025
Q2 | $860K | Sell |
70,277
-11,491
| -14% | -$145K | ﹤0.01% | 920 |
|
|
2025
Q1 | $1.17M | Buy |
81,768
+13,768
| +20% | +$215K | ﹤0.01% | 824 |
|
|
2024
Q4 | $1.08M | Buy |
68,000
+14,906
| +28% | +$295K | ﹤0.01% | 855 |
|
|
2024
Q3 | $1.28M | Sell |
53,094
-5,483
| -9% | -$125K | ﹤0.01% | 836 |
|
|
2024
Q2 | $1.17M | Hold |
58,577
| – | – | ﹤0.01% | 855 |
|
|
2024
Q1 | $1.17M | Buy |
+58,577
| New | +$1.13M | ﹤0.01% | 829 |
|
|
2023
Q2 | – | Sell |
-89,575
| Closed | -$2.66M | – | 1085 |
|
|
2023
Q1 | $2.66M | Hold |
89,575
| – | – | 0.01% | 705 |
|
|
2022
Q4 | $2.42M | Hold |
89,575
| – | – | 0.01% | 748 |
|
|
2022
Q3 | $1.95M | Sell |
89,575
-1,100
| -1% | -$28.7K | 0.01% | 761 |
|
|
2022
Q2 | $2.48M | Sell |
90,675
-23,525
| -21% | -$676K | 0.01% | 739 |
|
|
2022
Q1 | $3.83M | Sell |
114,200
-3,700
| -3% | -$119K | 0.01% | 722 |
|
|
2021
Q4 | $4.09M | Sell |
117,900
-12,000
| -9% | -$388K | 0.01% | 718 |
|
|
2021
Q3 | $4.05M | Hold |
129,900
| – | – | 0.01% | 733 |
|
|
2021
Q2 | $4.72M | Buy |
129,900
+100,600
| +343% | +$4.16M | 0.01% | 722 |
|
|
2021
Q1 | $1.28M | Buy |
+29,300
| New | +$1.38M | ﹤0.01% | 928 |
|
|
2020
Q4 | – | Sell |
-34,636
| Closed | -$1.15M | – | 1259 |
|
|
2020
Q3 | $1.15M | Sell |
34,636
-7,264
| -17% | -$232K | ﹤0.01% | 911 |
|
|
2020
Q2 | $1.23M | Hold |
41,900
| – | – | ﹤0.01% | 908 |
|
|
2020
Q1 | $1.13M | Buy |
41,900
+4,700
| +13% | +$140K | 0.01% | 833 |
|
|
2019
Q4 | $1.25M | Buy |
37,200
+5,000
| +16% | +$181K | 0.01% | 861 |
|
|
2019
Q3 | $1.21M | Buy |
32,200
+4,900
| +18% | +$187K | ﹤0.01% | 960 |
|
|
2019
Q2 | $1.19M | Buy |
+27,300
| New | +$1.17M | ﹤0.01% | 944 |
|
|
2018
Q2 | – | Sell |
-34,100
| Closed | -$1.57M | – | 1348 |
|
|
2018
Q1 | $1.57M | Sell |
34,100
-156,300
| -82% | -$7.42M | 0.01% | 902 |
|
|
2017
Q4 | $8.79M | Buy |
190,400
+47,600
| +33% | +$2.19M | 0.03% | 507 |
|
|
2017
Q3 | $6.43M | Buy |
142,800
+3,700
| +3% | +$158K | 0.03% | 565 |
|
|
2017
Q2 | $5.46M | Buy |
139,100
+73,200
| +111% | +$2.77M | 0.02% | 580 |
|
|
2017
Q1 | $2.51M | Buy |
65,900
+23,500
| +55% | +$916K | 0.01% | 733 |
|
|
2016
Q4 | $1.57M | Buy |
+42,400
| New | +$1.52M | 0.01% | 812 |
|
|
2016
Q3 | – | Sell |
-17,360
| Closed | -$565K | – | 1205 |
|
|
2016
Q2 | $565K | Sell |
17,360
-11,421
| -40% | -$350K | ﹤0.01% | 982 |
|
|
2016
Q1 | $827K | Buy |
+28,781
| New | +$767K | ﹤0.01% | 907 |
|
|
2015
Q4 | – | Sell |
-80,700
| Closed | -$2.29M | – | 1400 |
|
|
2015
Q3 | $2.29M | Buy |
+80,700
| New | +$2.82M | 0.01% | 753 |
|
|
2015
Q1 | – | Sell |
-8,180
| Closed | -$372K | – | 1428 |
|
|
2014
Q4 | $372K | Buy |
+8,180
| New | +$321K | ﹤0.01% | 1158 |
|
Other funds holding AVNS
AC
Axa's AVNS Position: Q3 2025 in Review
Axa sold out of Avanos Medical (AVNS) in Q3 2025, closing a stake of 70,277 shares — an estimated $860K sold.
Axa first reported a position in AVNS in Q4 2014 and held it in 31 quarters. The position peaked at $8.79M in Q4 2017. 276 funds tracked by Wall St. Rank hold AVNS as of Q3 2025.
- Axa reported no remaining Avanos Medical position as of Q3 2025 after selling out during the quarter.
- Axa sold 70,277 Avanos Medical shares in Q3 2025, an estimated $860K.
- Axa first reported a position in Avanos Medical in Q4 2014 and held it in 31 quarters.
- Axa's Avanos Medical position peaked at $8.79M in Q4 2017.
- 276 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2025.
Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.